We use cookies to analyse how visitors use our website and to help us provide the best possible experience for users. View our Cookie Policy for more information. Cookies help us analyse how visitors use our website & provide the best user experience. View our Cookie Policy.

Quayle Munro advises Dove Medical Press on its sale to Informa PLC

02 October 2017 in News & Insights

Quayle Munro is pleased to announce that it has advised Dove Medical Press, an Open Access (“OA”) publisher, on its sale to Taylor & Francis Group, a leading publisher of specialist academic books and journals and part of Informa PLC.

Dove Medical Press publishes primarily in the Health Sciences, with additional content in Science and Technology. Since its foundation in 2003, it has steadily built up an attractive portfolio of high quality OA journals including OncoTargets and Therapy (IF 2.612), Clinical Epidemiology (IF 7.056), International Journal of Chronic Obstructive Pulmonary Disease (IF 3.157), International Journal of Nanomedicine (IF 4.3). 86 of the journals are indexed in Clarivate’s Web of Science and 61 in PubMed.

Philip Smith, Director at Dove Medical Press, said: “We are delighted by the outcome of this transaction. Over the last 13 years, the aim of Dove Medical Press has been to make original, high quality medical and scientific research openly available. I believe that Taylor & Francis shares this vision, and for that reason, I am confident that they are best placed to nurture and grow the Dove journal portfolio. We are very appreciative of Quayle Munro’s strategic guidance and execution capability.”

Julian Moore, Managing Director at Quayle Munro, said: “We are very pleased to have advised the shareholders of Dove Medical Press on this transaction. We believe that Taylor & Francis is a great fit for the company.”

This transaction continues Quayle Munro’s recent work in the Publishing and Academic Research sectors. Quayle Munro has completed transactions involving Informa, RELX Group, Springer Nature and Thomson Reuters (Clarivate).

For transaction enquiries please contact:
Julian Moore
Tel: +44 (0)20 7907 4200
Email: julian.moore@quaylemunro.com

About Quayle Munro
Quayle Munro is an independent mergers and acquisitions advisory firm that has an extensive, global track record of working with a wide variety of companies underpinned by data & analytics, content, software and services. We advise on a full spectrum of corporate finance matters including mergers and acquisitions, debt and equity fundraisings, IPOs, public transactions, restructurings, and strategic and valuation advice. The company also provides growth capital on a selective basis. Quayle Munro is particularly adept at working with private-equity-owned and entrepreneurial-led businesses experiencing high growth. For more information please visit our website.

Share this article:

Back to News